B. R. Celli, W. Macnee, and A. Agusti, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, vol.23, pp.932-946, 2004.

J. Vestbo, S. S. Hurd, and A. G. Agustí, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med, vol.187, pp.347-365, 2013.

J. O'reilly, M. M. Jones, and J. Parnham, Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance, BMJ, vol.340, p.3134, 2010.

B. L. Rostron, C. M. Chang, and T. F. Pechacek, Estimation of cigarette smoking-attributable morbidity in the United States, JAMA Intern Med, vol.174, pp.1922-1928, 2014.

P. Jones, M. Miravitlles, and T. Van-der-molen, Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement, Int J Chron Obstruct Pulmon Dis, vol.7, pp.697-709, 2012.

T. Oga, K. Nishimura, and M. Tsukino, Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status, Am J Respir Crit Care Med, vol.167, pp.544-549, 2003.

H. O. Coxson and S. Lam, Quantitative assessment of the airway wall using computed tomography and optical coherence tomography, Proc Am Thorac Soc, vol.6, pp.439-443, 2009.

S. J. Copley, A. U. Wells, and N. L. Müller, Thin-section CT in obstructive pulmonary disease: discriminatory value, Radiology, vol.223, pp.812-819, 2002.

H. O. Coxson, J. Mayo, and S. Lam, New and current clinical imaging techniques to study chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.180, pp.588-597, 2009.

R. G. Barr, E. A. Berkowitz, and F. Bigazzi, A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation, COPD, vol.9, pp.151-159, 2012.

C. J. Galbán, M. K. Han, and J. L. Boes, Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression, Nat Med, vol.18, pp.1711-1715, 2012.

A. Christe, J. Charimo-torrente, and K. Roychoudhury, Accuracy of low-dose computed tomography (CT) for detecting and characterizing the most common CT-patterns of pulmonary disease, Eur J Radiol, vol.82, pp.142-150, 2013.

P. J. Castaldi, S. Estépar, R. Mendoza, and C. S. , Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers, Am J Respir Crit Care Med, vol.188, pp.1083-1090, 2013.

H. O. Coxson, J. Leipsic, and G. Parraga, Using pulmonary imaging to move COPD beyond FEV1, Am J Respir Crit Care Med, vol.190, pp.135-144, 2014.

J. A. Hardie, A. S. Buist, and W. M. Vollmer, Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers, Eur Respir J, vol.20, pp.1117-1122, 2002.

I. Cerveri, A. G. Corsico, and S. Accordini, Underestimation of airflow obstruction among young adults using FEV1/FVC < 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes, Thorax, vol.63, pp.1040-1045, 2008.

S. P. Bhatt, J. C. Sieren, and M. T. Dransfield, Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction, Thorax, vol.69, pp.409-414, 2014.

A. C. Carlsson, P. Wändell, and U. Ösby, High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden -a challenge for public health, BMC Public Health, vol.13, pp.670-678, 2013.

P. O. Bridevaux, M. W. Gerbase, and N. M. Probst-hensch, Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD, Thorax, vol.63, pp.768-774, 2008.

U. S. , Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.148, pp.529-534, 2008.

M. Ferrer, J. Alonso, and J. Morera, Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group, Ann Intern Med, vol.127, pp.1072-1079, 1997.

M. Friedman, C. W. Serby, and S. S. Menjoge, Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD, Chest, vol.115, pp.635-641, 1999.

P. S. Burge, P. M. Calverley, and P. W. Jones, Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, pp.1297-1303, 2000.

N. A. Dewan, S. Rafique, and B. Kanwar, Acute exacerbation of COPD: factors associated with poor treatment outcome, Chest, vol.117, pp.662-671, 2000.

N. R. Anthonisen, E. C. Wright, and J. E. Hodgkin, Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.133, pp.14-20, 1986.

M. B. Parshall, R. M. Schwartzstein, and L. Adams, An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea, Am J Respir Crit Care Med, vol.185, pp.435-452, 2012.

A. M. Schols, J. Slangen, and L. Volovics, Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1791-1797, 1998.

C. Landbo, E. Prescott, and P. Lange, Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.1856-1861, 1999.

D. A. Mahler, J. Ward, and L. A. Waterman, Patient-reported dyspnea in COPD reliability and association with stage of disease, Chest, vol.136, pp.1473-1479, 2009.

K. Nishimura, T. Izumi, and M. Tsukino, Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, vol.121, pp.1434-1440, 2002.

B. R. Celli, C. G. Cote, and J. M. Marin, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N Engl J Med, vol.350, pp.1005-1012, 2004.

C. G. Cote, V. M. Pinto-plata, and J. M. Marin, The modified BODE index: validation with mortality in COPD, Eur Respir J, vol.32, pp.1269-1274, 2008.

J. J. Soler-cataluña, M. A. Martínez-garcía, and L. S. Sánchez, Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients, Respir Med, vol.103, pp.692-699, 2009.

J. M. Marin, I. Alfageme, and P. Almagro, Multicomponent indices to predict survival in COPD: the COCOMICS study, Eur Respir J, vol.42, pp.323-332, 2013.

B. R. Celli, N. Locantore, and J. Yates, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.185, pp.1065-1072, 2012.

M. A. Puhan, J. Garcia-aymerich, and M. Frey, Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, Lancet, vol.374, pp.704-711, 2009.

R. C. Jones, G. C. Donaldson, and N. H. Chavannes, Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index, Am J Respir Crit Care Med, vol.180, pp.1189-1195, 2009.

M. Divo, C. Cote, and J. P. De-torres, Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.186, pp.155-161, 2012.

P. Almagro, J. B. Soriano, and F. J. Cabrera, Short-and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index, Chest, vol.145, pp.972-980, 2014.

A. Agustí, J. A. Barberà, and E. Wouters, Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.188, pp.1396-1406, 2013.

G. C. Donaldson, T. Seemungal, and A. Bhowmik, Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, vol.57, pp.847-852, 2002.

J. Vestbo, L. D. Edwards, and P. D. Scanlon, Changes in forced expiratory volume in 1 second over time in COPD, N Engl J Med, vol.365, pp.1184-1192, 2011.

N. Freimer and C. Sabatti, The human phenome project, Nat Genet, vol.34, pp.15-21, 2003.

M. K. Han, A. Agusti, and P. M. Calverley, Chronic obstructive pulmonary disease phenotypes: the future of COPD, Am J Respir Crit Care Med, vol.182, pp.598-604, 2010.

J. M. Drazen and L. M. Fabbri, Ageing and multimorbidity, Eur Respir J, vol.44, p.557, 2014.

R. Faner, T. Cruz, and A. López-giraldo, Network medicine, multimorbidity and the lung in the elderly, Eur Respir J, vol.44, pp.775-788, 2014.

M. J. Divo, C. H. Martinez, and D. M. Mannino, Ageing and the epidemiology of multimorbidity, Eur Respir J, vol.44, pp.1055-1068, 2014.

A. R. Patel, G. C. Donaldson, and A. J. Mackay, The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD, Chest, vol.141, pp.851-857, 2012.

D. M. Mannino, D. Thorn, and A. Swensen, Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J, vol.32, pp.962-969, 2008.

J. P. De-torres, J. M. Marín, and C. Casanova, Lung cancer in patients with chronic obstructive pulmonary diseaseincidence and predicting factors, Am J Respir Crit Care Med, vol.184, pp.913-919, 2011.

D. O. Wilson, J. K. Leader, and C. R. Fuhrman, Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh lung screening study, J Thorac Oncol, vol.6, pp.1200-1205, 2011.

L. E. Vanfleteren, M. A. Spruit, and M. Groenen, Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.187, pp.728-735, 2013.

G. C. Donaldson, J. R. Hurst, and C. J. Smith, Increased risk of myocardial infarction and stroke following exacerbation of COPD, Chest, vol.137, pp.1091-1097, 2010.

R. P. Bowler, V. Kim, and E. Regan, Prediction of acute respiratory disease in current and former smokers with and without COPD, Chest, vol.146, pp.941-950, 2014.

W. C. Tan, J. Bourbeau, and P. Hernandez, Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study, Thorax, vol.69, pp.709-717, 2014.

J. M. Marin, J. B. Soriano, and S. J. Carrizo, Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome, Am J Respir Crit Care Med, vol.182, pp.325-331, 2010.

P. Jha and R. Peto, Global effects of smoking, of quitting, and of taxing tobacco, N Engl J Med, vol.370, pp.60-68, 2014.

N. R. Anthonisen, J. E. Connett, and R. P. Murray, Smoking and lung function of Lung Health Study participants after 11 years, Am J Respir Crit Care Med, vol.166, pp.675-679, 2002.

G. Parkes, T. Greenhalgh, and M. Griffin, Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial, BMJ, vol.336, pp.598-600, 2008.

M. Bednarek, D. Gorecka, and J. Wielgomas, Smokers with airway obstruction are more likely to quit smoking, Thorax, vol.61, pp.869-873, 2006.

G. Stratelis, S. Mölstad, and P. Jakobsson, The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD, Scand J Prim Health Care, vol.24, pp.133-139, 2006.

D. Kotz, G. Wesseling, and M. Huibers, Efficacy of confronting smokers with airflow limitation for smoking cessation, Eur Respir J, vol.33, pp.754-762, 2009.

D. Tashkin, R. Kanner, and W. Bailey, Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, vol.357, pp.1571-1575, 2001.

D. P. Tashkin, S. Rennard, and J. T. Hays, Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial, Chest, vol.139, pp.591-599, 2011.

P. Tønnesen, K. Mikkelsen, and L. Bremann, Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support, Chest, vol.130, pp.334-342, 2006.

E. J. Wagena, R. M. Van-der-meer, and R. J. Ostelo, The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review, Respir Med, vol.98, pp.805-815, 2004.

I. Wilson, Depression in the patient with COPD, Int J Chron Obstruct Pulmon Dis, vol.1, pp.61-64, 2006.

N. A. Rigotti, A. L. Pipe, and N. L. Benowitz, Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial, Circulation, vol.121, pp.221-229, 2010.

E. F. Ellerbeck, J. D. Mahnken, and A. P. Cupertino, Effect of varying levels of disease management on smoking cessation: a randomized trial, Ann Intern Med, vol.150, pp.437-446, 2009.

M. C. Fiore, C. R. Jaen, and T. B. Baker, Treating tobacco use and dependence: 2008 update. Clinical Practice Guidelines, Department of Health and Human Services, 2008.

T. J. Crowley, M. J. Macdonald, and M. I. Walter, Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients, Psychopharmacology (Berl), vol.119, pp.193-204, 1995.

J. Etter, C. Bullen, and A. D. Flouris, Electronic nicotine delivery systems: a research agenda, Tob Control, vol.20, pp.243-248, 2011.

J. Etter and C. Bullen, Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy, Addiction, vol.106, pp.2017-2028, 2011.

M. K. Goniewicz, E. O. Lingas, and P. Hajek, Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey, Drug Alcohol Rev, vol.32, pp.133-140, 2013.

J. F. Bertholon, M. H. Becquemin, and I. Annesi-maesano, Electronic cigarettes: a short review, Respiration, vol.86, pp.433-438, 2013.

D. E. Schraufnagel, F. Blasi, and M. B. Drummond, Electronic cigarettes. A position statement of the forum of international respiratory societies, Am J Respir Crit Care Med, vol.190, pp.611-618, 2014.

A. S. Buist, G. J. Sexton, and J. M. Nagy, The effect of smoking cessation and modification on lung function, Am Rev Respir Dis, vol.114, pp.115-122, 1976.

C. Jiménez-ruiz, S. Solano, and S. A. Viteri, Harm reduction -a treatment approach for resistant smokers with tobacco-related symptoms, Respiration, vol.69, pp.452-455, 2002.

S. I. Rennard, D. Daughton, and J. Fujita, Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers, Eur Respir J, vol.3, pp.752-759, 1990.

M. S. Simmons, J. E. Connett, and M. A. Nides, Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study, Eur Respir J, vol.25, pp.1011-1017, 2005.

J. R. Hughes and M. J. Carpenter, Does smoking reduction increase future cessation and decrease disease risk? A qualitative review, Nicotine Tob Res, vol.8, pp.739-749, 2006.

J. M. Tetrault, K. Crothers, and B. A. Moore, Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review, Arch Intern Med, vol.167, pp.221-228, 2007.

P. M. Calverley, J. A. Anderson, and B. Celli, Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, vol.356, pp.775-789, 2007.

D. P. Tashkin, B. Celli, and S. Senn, A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.1543-1554, 2008.

C. R. Jenkins, P. W. Jones, and P. M. Calverley, Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study, Respir Res, vol.10, p.59, 2009.

P. R. Burgel, J. L. Paillasseur, and D. Dusser, Tiotropium might improve survival in subjects with COPD at high risk of mortality, Respir Res, vol.15, p.64, 2014.

B. R. Celli, N. E. Thomas, and J. A. Anderson, Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study, Am J Respir Crit Care Med, vol.178, pp.332-338, 2008.

M. Decramer, B. Celli, and S. Kesten, Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial, Lancet, vol.374, pp.1171-1178, 2009.

J. Chong, C. Karner, and P. Poole, Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.9, p.9157, 2012.

K. F. Rabe, L. M. Fabbri, and E. Israel, Effect of ADRB2 polymorphism on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial, Lancet Respir Med, vol.2, pp.44-53, 2014.

M. L. Decramer, K. R. Chapman, and R. Dahl, Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study, Lancet Respir Med, vol.1, pp.524-533, 2013.

P. M. Calverley, R. A. Stockley, and T. A. Seemungal, Reported pneumonia in patients with COPD: findings from the INSPIRE study, Chest, vol.139, pp.505-512, 2011.

C. Crim, P. M. Calverley, and J. A. Anderson, Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results, Eur Respir J, vol.34, pp.641-647, 2009.

J. A. Wedzicha, P. M. Calverley, and T. A. Seemungal, The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, Am J Respir Crit Care Med, vol.177, pp.19-26, 2008.

S. D. Aaron, K. L. Vandemheen, and D. Fergusson, Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.146, pp.545-555, 2007.

J. A. Wedzicha, M. Decramer, and J. H. Ficker, Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study, Lancet Respir Med, vol.1, pp.199-209, 2013.

H. Magnussen, B. Disse, and R. Rodriguez-roisin, Withdrawal of inhaled glucocorticoids and exacerbations of COPD, N Engl J Med, vol.371, pp.1285-1294, 2014.

L. C. Price, D. Lowe, and H. S. Hosker, UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation, Thorax, vol.61, pp.837-842, 2006.

F. H. Rutten, N. P. Zuithoff, and E. Hak, Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease, Arch Intern Med, vol.170, pp.880-887, 2010.

Y. Nussbaumer-ochsner and K. F. Rabe, Systemic manifestations of COPD, Chest, vol.139, pp.165-173, 2011.

M. A. Spruit, S. J. Singh, and C. Garvey, statement: key concepts and advances in pulmonary rehabilitation, Am J Respir Crit Care Med, vol.188, pp.13-64, 2013.

D. S. Vieira, F. Maltais, and J. Bourbeau, Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients, Curr Opin Pulm Med, vol.16, pp.134-143, 2010.

F. Maltais, J. Bourbeau, and S. Shapiro, Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.149, pp.869-878, 2008.

C. R. Van-wetering, M. Hoogendoorn, and S. J. Mol, Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial, Thorax, vol.65, pp.7-13, 2010.

C. R. Van-wetering, M. Hoogendoorn, and R. Broekhuizen, Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial, J Am Med Dir Assoc, vol.11, pp.179-187, 2010.

M. A. Puhan, E. Gimeno-santos, and M. Scharplatz, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.10, p.5305, 2011.

R. Casaburi, D. Kukafka, and C. B. Cooper, Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD, Chest, vol.127, pp.809-817, 2005.

, Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party, Lancet, vol.1, pp.681-686, 1981.

, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group, Ann Intern Med, vol.93, pp.391-398, 1980.

D. Górecka, K. Gorzelak, and P. Sliwi?ski, Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia, Thorax, vol.52, pp.674-679, 1997.

L. Brochard, J. Mancebo, and M. Wysocki, Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, vol.333, pp.817-822, 1995.

J. Bott, M. P. Carroll, and J. H. Conway, Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease, Lancet, vol.341, pp.1555-1557, 1993.

N. Kramer, T. J. Meyer, and J. Meharg, Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure, Am J Respir Crit Care Med, vol.151, pp.1799-1806, 1995.

P. K. Plant, J. L. Owen, and M. W. Elliott, Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial, Lancet, vol.355, pp.1931-1935, 2000.

S. Nava and N. Hill, Non-invasive ventilation in acute respiratory failure, Lancet, vol.374, pp.250-259, 2009.

S. P. Bhatt, M. W. Peterson, and J. S. Wilson, Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.581-589, 2013.

B. Lamia, A. Cuvelier, and J. Benichou, Bénéfices de la ventilation non invasive a domicile au décours d'une insuffisance respiratoire aigue hypercapnique chez les patients BPCO. Etude contrôlée randomisée multicentrique. Etude Non Invasive Ventilation in Obstructive Lung Disease (Nivold) [A multi-centre randomized controlled trial of domiciliary non-invasive ventilation vs long-term oxygen therapy in survivors of acute hypercapnic respiratory failure due to COPD. Non-invasive ventilation

, Rev Mal Respir, vol.29, pp.1141-1148, 2012.

E. Clini, C. Sturani, and A. Rossi, The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients, Eur Respir J, vol.20, pp.529-538, 2002.

F. M. Struik, R. T. Sprooten, and H. A. Kerstjen, Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomized, controlled, parallel-group study, Thorax, vol.69, pp.826-834, 2014.

F. M. Struik, Y. Lacasse, and R. S. Goldstein, Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis, Respir Med, vol.108, pp.329-337, 2014.

T. Kohnlein, W. Windisch, and D. Kohler, Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial, Lancet Respir Med, vol.2, pp.698-705, 2014.